Member Info for Bella6532

Based on your handles, I'll guessing you're mainly men...if so, don't ever have a go at women for talking rubbish all the time.
You guys ae just coming across like a bunch of grumpy old men with nothing better to do.

License Agreement with Astrea Bioseparations for the use of the Affimer platform for affinity purification applications..
Very little discussion about this...and in itself could be an industry game changer....

AVACTA had £47.9m cash at the end of the year, having incurred losses of £18.9m.

Upcoming milestones include self-declaration of the CE mark of its Covid test for professional use and commercial launch in early May, and the first data on the effectiveness of its targeted chemotherapy platform pre|CISION in humans by the end of the year.

AVACTA is about affimers..New tech which is already being picked up in different areas other than LFTs...
Don't be blinkered by pure test play...affimers are a new and far more accurate industry disrupter at the very very early stages of its life span...

Jamins - spot on...the US also created Spin...this was spun out as a proposal as you say to keep his lefties happy...

22 Feb to 28 Feb = down
14 Mar to 25 Mar = down
14 Apr to 23 Apr = down

1 Mar to 13 Mar = Up
26 Mar to 13 Apr = Up
26 Apr to 13 May = ?????

What more o you need to know:
'Currently the most sensitive S1 spike lateral flow test available.'

By end next week: ‘The CE mark will then be transferred to Avacta after it receives ISO13485 accreditation, which is expected in April 2021’

Week of 3rd or 12th May: ‘We are now very close to self-declaration of the CE mark of the AffiDX® rapid antigen test for professional use and COMMERCIAL LAUNCH IN EARLY MAY’

The next Government roadmap date is 13 May…my guess is our launch will be no later than 13th May with shipping taking place prior.

Hang in there chaps...our commercial launch is only a matter or days away now...

Great...it proves we're a great company....derampers NEVER deramp bad companies...
Funny how they always disappear when price rises and it will...just sit tight...

Livedataaccount...today has been about giving iis the heads up and they will be buying in...unfortunately they will hard ball their order price so good chance we'll see this dip. The next couple of RNSs will support their buy in and they will want to be in when the Govt contract is announced early May...then this will rip and all our angst will be history...
Today was for it's not pi's...

I thought Stratton had just been moved over as spokesperson for COP26 not for Boris.
That letter sounds more like how Boris would word a reply not a special advisor...

The following is the next roadmap stage...and there's going to be a need for a lot of test kits and they will need to be made available at least a week or so beforehand so this all fits with our early May timing and mass testing statements...go Bojo...bring them on...
'Step 3, no earlier than 17 May:
Outdoors, most social contact rules will be lifted - although gatherings of over 30 people will remain illegal.
Outdoor performances such as outdoor cinemas, outdoor theatres and outdoor cinemas can reopen.. Indoors, the rule of 6 or 2 households will apply - although we will keep under review whether it is safe to increase this.
Indoor hospitality, entertainment venues such as cinemas and soft play areas, the rest of the accommodation sector, and indoor adult group sports and exercise classes will also reopen.
Larger performances and sporting events in indoor venues with a capacity of 1,000 people or half-full (whichever is lower) will also be allowed, as will those in outdoor venues with a capacity of 4000 people or half-full (whichever is lower).
In the largest outdoor seated venues where crowds can spread out, up to 10,000 people will be able to attend (or a quarter-full, whichever is lower).
Up to 30 people will be able to attend weddings, receptions and wakes, as well as funerals. Other life events that will be permitted include bar mitzvahs and christenings.'

PL75...agree with your summary and following is from todays RNS...
'The collaboration with Mologic also provides initial manufacturing capacity with the benefit of a short set-up time for the lateral flow test with Global Access Diagnostics ('GAD'), in addition to the agreements with BBI Group, Abingdon Health and others, that will provide manufacturing capabilities that can be scaled to several millions of tests per month.'

'OtherS'....we know about Omega but who else is out there?
Who have they got lined up to manufacture in Europe?
Further updates next couple if weeks and possibly a European manufacturing deal...

Does hybrid = cheaper.

Well if there are any shorter left with open positions they are being royally hammered....

Big grin here...

Muller12...And mass testing...

PJT12..totally agree...and diagnostics will create huge income streams and most if all put Avacta and our affimer technology firmly on the map which should all add to an easier route to market for our therapeutics. Money in the bank and fame always helps get things done...

Dropped to fill upcoming orders...
They have seen where the stop losses are set and they're going after them. A good sign in my opinion...

Vicente...agree but if dropped in favour of sisal swab they could have mentioned this in Post section...

'COMMERCIAL LAUNCH IN EARLY MAY'....these are the most important words in there....

·' The collaboration with Mologic also provides initial manufacturing capacity with the benefit of a short set-up time for the lateral flow test with Global Access Diagnostics ('GAD'), in addition to the agreements with BBI Group, Abingdon Health and others, that will provide manufacturing capabilities that can be scaled to several millions of tests per month.'

Note..'and others'..Omega? UKGovt...can't mention names...